Speech-Language Pathologists in Pahoa, HI Accepting Medicare
1 Speech-Language Pathologists found. Showing 1 - 1
 Scott Andrew Erickson, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15-890 Kahakai Blvd, Pahoa, HI 96778 Phone: 808-965-2131 |
News Archive
GTSI awarded Biometric Automated Toolset-Army contract
GTSI Corp., a leading information technology systems integrator for federal, state and local governments, announced today the award of the Biometric Automated Toolset-Army (BAT-A) contract by the U.S. Army.
Sagard Capital to acquire IntegraMed
IntegraMed America, Inc., a leader in developing, marketing and managing specialty healthcare facilities in the fertility and vein care markets, announced today that it has entered into a definitive agreement to be acquired by affiliates formed by Sagard Capital Partners, L.P., an investment fund and IntegraMed shareholder, for $14.05 per share in cash, or a total equity purchase price of $169.5 million.
FDA approves Takeda's Entyvio for severe active ulcerative colitis and Crohn's disease
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., has announced that the United States (U.S.) Food and Drug Administration (FDA) simultaneously approved a new biologic therapy, Entyvio™ (vedolizumab), for the treatment of adults with moderately to severely active ulcerative colitis (UC) and Crohn's disease (CD).
Cedars-Sinai Heart Institute presents new findings on heart transplantation rejection factors
Physician scientists at the Cedars-Sinai Heart Institute are presenting new findings on heart transplantation rejection factors such as race and gender, the effects of pre-transplant smoking and whether homeless organ donors put recipients at higher risk for complications. The presentations will take place April 21 - 24 in Chicago during the 30th Annual Scientific Meeting of the International Society of Heart and Lung Transplantation.
Adaptive Biotechnologies demonstrates use of high-throughput sequencing platform for MRD
Adaptive Biotechnologies, the leader in combining next-generation sequencing (NGS) and expert bioinformatics to profile T- and B-cell receptors of the adaptive immune system, and collaborators will be presenting five studies demonstrating how Adaptive's high-throughput sequencing platform enables diagnosis, detection and assessment of prognosis in hematological malignances and has increased sensitivity over flow cytometry.
› Verified 9 days ago